GSK lifts annual profit forecast after third quarter beat on vaccines strength Medical Dialogues Bureau31 Oct 2019 9:00 AM ISTGSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
Bumper crop of new drugs fails to lift big pharma Research and Development returns Ruby Khatun Khatun16 Dec 2017 9:45 AM ISTLONDON: It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
